News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitcoin adoption ‘booming’ while price chops: Which metrics matter most?2Bitget UEX Daily ｜US-Iran Conflict Escalates, Shaking Markets; Oil Prices, Gold and Silver Surge, Stock Index Futures Fall; Tech Stocks Show Mixed Performance (March 02, 2026)3SEC approval sought for JitoSOL Solana-based liquid staking token ETF
U.S. equities drop at the start as Iran tensions drive oil higher and investors seek safe havens
101 finance·2026/03/02 14:57
TEGNA Inc. (TGNA) Exceeds Q4 Expectations for Earnings and Revenue
101 finance·2026/03/02 14:48
NVIDIA and AST SpaceMobile have been featured as Zacks Bull and Bear of the Day
101 finance·2026/03/02 14:48
Black Hills: Does the $37 Million Whale Wager Indicate a Wise Move or a Potential Pitfall?
101 finance·2026/03/02 14:46
Paramount CEO says Warner Bros tie-up to carry $79 billion net debt, no cable asset sales planned
101 finance·2026/03/02 14:39
WBD Q4 Results Fall Short Due to Drop in Linear TV and Underperforming Studios
101 finance·2026/03/02 14:36
Based On This Ripple CEO Statement, Pundit Says Swap Your Bitcoin for XRP ASAP
TimesTabloid·2026/03/02 14:33
Analysis-Hims expansion may not come in time for risky GLP-1 business
101 finance·2026/03/02 14:27
Zacks Begins Coverage on JVA, Assigns Outperform Rating
101 finance·2026/03/02 14:27
MTDR Q4 Results Surpass Expectations Thanks to Increased Output
101 finance·2026/03/02 14:27
Flash
14:45
Klaviyo, Inc. (KVYO) stock price rises significantly, up by 7.4%This surge is attributed to the company's announcement of a stock repurchase plan totaling $500 millions, which includes a $100 millions accelerated stock repurchase arrangement. This move sends a strong signal to the market regarding the management's confidence in the company's future prospects and intrinsic value, while also demonstrating its clear intention to enhance shareholder value through capital returns.
14:45
According to the latest documents submitted to the U.S. Securities and Exchange Commission (SEC), biopharmaceutical company Bioxytran, Inc. has achieved positive safety data in its clinical research process.The document clearly states that no reports of serious adverse events occurred during the trial, and all participants completed the prescribed treatment regimen without any interruptions due to treatment-related reasons. This outcome highlights the tolerability of the company's investigational therapy, providing key safety evidence for subsequent clinical advancement. In the current biotech landscape, where drug safety is highly scrutinized, such data undoubtedly strengthens investors' confidence in the research and development process.
14:44
Bofa Global Research has released its latest research report, initiating coverage on Bob’s Discount Furniture, Inc. for the first time and assigning it a "Buy" rating.The report sets a target price of $28 for the stock.
News